FASEB Releases Data on NIH Research Funding Trends, Highlights the Need for Sustained Funding in FY2011
Date: April 07, 2010
The Federation of American Societies for Experimental Biology (FASEB) has released an updated compilation of data
on research funding at the National Institutes of Health (NIH), as well as a statement
about how current trends could affect biomedical research in FY2011. “Based on projections from the President’s budget summary, we will see a significant decline in the number of grants in FY2011 at the proposed funding level,” said Howard Garrison, Ph.D., Director of FASEB’s Office of Public Affairs and author of the data resource. “This represents a reduction of research capacity and the potential delay or interruption of promising new efforts to find treatments and cures for life-threatening diseases.”
“While it is clear the President recognized the importance of investing in biomedical research, based on the 3.2 percent increase he proposed in his FY2011 budget, the supplemental appropriations the agency received in FY2010 has created a wealth of emerging opportunities that cannot be ignored,” stated Mark O. Lively, Ph.D., FASEB President, “We want to ensure that policymakers understand that our progress against devastating conditions like cancer and Alzheimer’s disease depends on sustaining the momentum of our current enterprise. This is more than just a trend in data; it is symbolic of a diminishment of hope.”
FASEB hopes the series of graphs and analysis, which provides information on expenditures for research grants, grant numbers, success rates, and average award sizes, will help policymakers understand the case for sustained funding for biomedical research. To that end, FASEB has recommended that Congress appropriate $37 billion for NIH in FY2011.
To view the FASEB NIH data resource, please visit: http://www.faseb.org/Policy-and-Government-Affairs/Data-Compilations/NIH-Research-Funding-Trends.aspx